posted on 2017-01-10, 20:45authored byJi Hoon Phi, Naoko Suzuki, Youn Joo Moon, Ae Kyung Park, Kyu-Chang Wang, Ji Yeoun Lee, Seung-Ah Choi, Sangjoon Chong, Reizo Shirane, Seung-Ki Kim
(A) In trans-well migration assays (n = 3 for each group), treatment of CCR5 siRNAs effectively abrogates the enhanced migration of MMD SPCs by the presence of MMD ECFCs or addition of rhCCL5. (B) Quantification of migrated cells.